Log In
Print
BCIQ
Print
Print this Print this
 

paroxetine (Brisdelle) (formerly Mesafem)

Also known as: low-dose paroxetine mesylate (low-dose mesylate salt of paroxetine (LDMP))

  Manage Alerts
Collapse Summary General Information
Company Hisamitsu Pharmaceutical Co. Inc.
DescriptionLow-dose paroxetine mesylate, a selective serotonin reuptake inhibitor (SSRI)
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationMenopause
Indication DetailsTreat vasomotor symptoms associated with menopause
Regulatory Designation

U.S. - Special Protocol Assessment (Treat vasomotor symptoms associated with menopause);
U.S. - Undisclosed Review (Treat vasomotor symptoms associated with menopause)

Partner

Shionogi & Co. Ltd.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today